Related Experiment Video
Updated: Feb 14, 2026

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
Long non-coding RNA RP11-552M11.4 promotes cells proliferation, migration and invasion by targeting BRCA2 in ovarian
Kejin Huang1, Jiashi Geng1, Jing Wang1
1Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China.
Abstract:
The present study aimed to investigate the effect of long non-coding RNA (lncRNA) RP11-552M11.4 on cell proliferation, apoptosis, migration and invasion as well as its targeting genes in epithelial ovarian cancer (EOC) cells. LncRNA RP11-552M11.4 expression was detected in 67 tumor tissues and paired adjacent tissues obtained from EOC patients. lncRNA RP11-552M11.4 mimic/inhibitor plasmids were transferred into ovarian cancer cells (SKOV3, A-2780) and normal ovarian epithelial cells (IOSE80 cells). In addition, rescue experiment was carried out by transferring BRCA2 inhibitor&lncRNA RP11-552M11.4 inhibitor plasmids into SKOV3 and A-2780 cells. qPCR, western blot, CKK-8, Annexin V/propidium iodide (AV/PI), wound-healing and Matrigel invasion assays were carried out to detect RNA expression, protein expression, cell proliferation, apoptosis, migration, and invasion, respectively. LncRNA RP11-552M11.4 expression was elevated in tumor tissues compared with paired adjacent tissues and correlated with higher pathological grade, International Federation of Gynecology and Obstetrics stage and worse overall survival in EOC patients. LncRNA RP11-552M11.4 promoted SKOV3 cell proliferation, migration and invasion whereas it inhibited apoptosis. Rescue experiment and luciferase reporter assay showed that lncRNA RP11-552M11.4 regulated SKOV3 cells functions through binding BRCA2. Further experiments in A-2780 cells also validated that lncRNA RP11-552M11.4 induced A-2780 cell proliferation while repressing apoptosis by targeting BRCA2. In addition, upregulation of lncRNA RP11-552M11.4 increased IOSE80 cell proliferation, migration and invasion while decreasing apoptosis. In conclusion, lncRNA RP11-552M11.4 correlates with worse prognosis, and promotes cell proliferation, migration, invasion, and inhibits cell apoptosis by down-regulating BRCA2 in EOC.
Insights
Long non-coding RNA RP11-552M11.4 promotes epithelial ovarian cancer progression by increasing cell proliferation, migration, and invasion while inhibiting apoptosis. This lncRNA targets BRCA2, correlating with worse patient prognosis and advanced disease stages.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Epithelial ovarian cancer (EOC) remains a leading cause of cancer-related mortality.
- The role of long non-coding RNAs (lncRNAs) in EOC pathogenesis is increasingly recognized.
- Identifying novel molecular targets is crucial for improving EOC treatment strategies.
Purpose of the Study:
- To investigate the functional role of lncRNA RP11-552M11.4 in epithelial ovarian cancer (EOC).
- To determine the impact of lncRNA RP11-552M11.4 on cancer cell proliferation, apoptosis, migration, and invasion.
- To elucidate the underlying molecular mechanism, including its interaction with target genes like BRCA2.
Main Methods:
- Quantitative real-time PCR (qPCR) and Western blot for gene and protein expression analysis.
- Cell Counting Kit-8 (CCK-8), Annexin V/propidium iodide (AV/PI) assays for proliferation and apoptosis.
- Wound-healing and Matrigel invasion assays for migration and invasion.
- Luciferase reporter assays and rescue experiments to confirm gene targeting.
Main Results:
- LncRNA RP11-552M11.4 expression was significantly upregulated in EOC tumor tissues compared to adjacent tissues.
- Elevated lncRNA RP11-552M11.4 levels correlated with higher pathological grade, advanced FIGO stage, and poorer overall survival.
- Overexpression of lncRNA RP11-552M11.4 promoted proliferation, migration, and invasion, while inhibiting apoptosis in EOC cells (SKOV3, A-2780).
- LncRNA RP11-552M11.4 exerted its effects by downregulating BRCA2 expression, as confirmed by rescue experiments and luciferase assays.
Conclusions:
- LncRNA RP11-552M11.4 is an oncogenic lncRNA in EOC, associated with adverse clinical outcomes.
- It promotes EOC progression by enhancing cell proliferation, migration, and invasion, and suppressing apoptosis.
- Targeting lncRNA RP11-552M11.4 or its interaction with BRCA2 may represent a potential therapeutic strategy for EOC.
Related Concept Videos
Cancer Cell Migration through Invadopodia
lncRNA - Long Non-coding RNAs
The Eukaryotic Promoter Region
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cell Migration
Cell Migration

